Effectiveness and safety of tocilizumab therapy for rheumatoid artritis patients

Effectiveness and safety of tocilizumab therapy for rheumatoid artritis patients - Effectiveness of tocilizumab therapy for rheumatoid artjritis patients complicated with interstitial pneumonia.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021004

Enrollment

Registered

2016-02-13

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis complicated with interstitial pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rheumatoid arthrit patients with high disease activity and chronic fibrosing interstitial lung disease

Exclusion criteria

Exclusion criteria: Patients who does not agree to tocilizumab therapy

Design outcomes

Primary

Measure	Time frame
1)Improvement of disease activity of rheumatoid arthritis 2)Change of severerity of interstitial pneumonia (stage, forced volume capacity)	—

Countries

Japan

Contacts

Public ContactShunichi Tsutumiuchi

2659 Suya, Kohshi, Kumamoto Japan Secretariat

8211sy01@hosp.go.jp81-96-242-1000

Outcome results